Thomas Krivak, MD, Allegheny Health Network, gives a quick summary of a clinical trial that assessed niraparib in the frontline setting for high-risk patients with ovarian cancer and numerous poor prognostic factors.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
